Alpers-huttenlocher syndrome

Pediatric Neurology

Volumn 48, Issue 3, 2013, Pages 167-178

  Saneto, Russell P ^a   Cohen, Bruce H ^b   Copeland, William C ^c   Naviaux, Robert K ^d  

^a UNIVERSITY OF WASHINGTON   (United States)

^b AKRON CHILDREN'S HOSPITAL   (United States)

^c NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBAMAZEPINE; DNA DIRECTED DNA POLYMERASE GAMMA; ETIRACETAM; HOLOENZYME; LAMOTRIGINE; MITOCHONDRIAL DNA; OXCARBAZEPINE; PHENOBARBITAL; PHENYTOIN; PRIMIDONE; TOPIRAMATE; VALPROIC ACID;

ALPERS DISEASE; APNEA; ARTIFICIAL VENTILATION; ATHETOSIS; BRAIN DISEASE; CARDIOMYOPATHY; CHOREA; CLINICAL FEATURE; CONGESTIVE HEART FAILURE; CONSULTATION; DETERIORATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA CONTENT; DRUG SUBSTITUTION; DYSPHAGIA; ECOLOGICAL GENETICS; ELECTROENCEPHALOGRAM; ENVIRONMENTAL FACTOR; ENZYMOLOGY; FEBRILE CONVULSION; GASTROSTOMY; GENE MUTATION; GENETIC SCREENING; GENETIC VARIABILITY; GLUCONEOGENESIS; HUMAN; HYDRATION; HYPERAMMONEMIA; HYPOVENTILATION; INTESTINAL DYSMOTILITY; INTRACTABLE EPILEPSY; LIVER DYSFUNCTION; LIVER FAILURE; LIVER TRANSPLANTATION; MITOCHONDRIAL DNA DEPLETION SYNDROME; MOTOR DYSFUNCTION; MYOCEREBROHEPATOPATHY; NEUROIMAGING; NUTRITION; OCCUPATIONAL THERAPY; ONSET AGE; PALLIATIVE THERAPY; PANCREATITIS; PHYSIOTHERAPY; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY CHAIN; REVIEW; SEIZURE; SEX RATIO; SPEECH THERAPY; STOMACH TUBE; TOTAL PARENTERAL NUTRITION; TREATMENT INDICATION; VIRUS INFECTION;

DIFFUSE CEREBRAL SCLEROSIS OF SCHILDER; DISEASE PROGRESSION; EPILEPSIA PARTIALIS CONTINUA; HUMANS; LIVER FAILURE; MITOCHONDRIA; STATUS EPILEPTICUS;

EID: 84873952089     PISSN: 08878994     EISSN: 18735150     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2012.09.014     Document Type: Review

References (78)

1. B.J. Alpers Diffuse progressive degeneration of the gray matter of the cerebrum Arch Neurol Psychiatry 25 1931 469 505
2. W.M. Bullard Diffuse cortical sclerosis of the brain in children J Nerv Ment Dis 15 1890 699 709
3. P.R. Huttenlocher, G.B. Solitare, and G. Adams Infantile diffuse cerebral degeneration with hepatic cirrhosis Arch Neurol 33 1976 186 192
4. U. Sandback, and P. Lerman Progressive cerebral poliodystrophy-Alpers' disease: Disorganized giant neuronal mitochondria on electron microscopy J Neurol Neurosurg Psychiatry 35 1972 749 755
5. B.N. Harding Progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher syndrome): A personal review J Child Neurol 5 1990 273 287
6. J. Eggar, B.N. Harding, S.G. Boyd, J. Wilson, and M. Erdohazi Progressive neuronal degeneration of childhood (PNDC) with liver disease Clin Pediatr (Phila) 26 1987 167 173
7. K.V. Nguyen, F.S. Sharief, S.S.L. Chan, W.C. Copeland, and R.K. Naviaux Molecular diagnosis of Alpers syndrome J Hepatol 45 2006 108 116
8. P.A. Ropp, and W.C. Copeland Cloning and characterization of the human mitochondrial DNA polymerase gamma Genomics 35 1996 449 458
9. R.K. Naviaux, W.J. Nyhan, and B.A. Barshop Mitochondrial DNA polymerase gamma deficiency and mtDNA depletion in a child with Alpers syndrome Ann Neurol 25 1999 54 58
10. G. Van Goethem, B. Dermaut, A. Lofgren, J.J. Martin, and C. Van Broeckhoven Mutation of POLG is associated with progressive external ophthalmoplegia characterization by mtDNA deletions Nat Genet 28 2001 211 212
11. R.K. Naviaux, and K.V. Nguyen POLG mutations associated with Alpers syndrome and mitochondrial DNA depletion Ann Neurol 55 2004 706 712
12. L.-J.C. Wong, R.K. Naviaux, and N. Brunetti-Pierri Molecular and clinical genetics of mitochondrial diseases due to POLG mutations Hum Mutat 29 2008 E150 E172
13. S. Tang, J. Wang, and N.-C. Lee Mitochondrial DNA polymerase γ mutations: An ever expanding molecular and clinical spectrum J Med Genet 48 2011 669 681
14. R.P. Saneto, and R.K. Naviaux Polymerase gamma disease through the ages Dev Disabil Res Rev 16 2010 163 174
15. B.H. Cohen, P.F. Chinnery, and W.C. Copeland GeneReviews at Gene Tests: Medical genetics information resource 2010 University of Washington Seattle Available at: http://www.genetests.org
16. B.H. Cohen, and R.K. Naviaux The clinical diagnosis of POLG disease and other mitochondrial DNA depletions disorders Methods 51 2010 364 373
17. M.J. Blok, B.J. van den Bosch, and E. Jongen The unfolding clinical spectrum of POLG mutations J Med Genet 46 2009 776 785
18. A. Spinazzola, and M. Zeviani Disorders from perturbations of nuclear-mitochondrial intergenomic cross-talk J Intern Med 265 2009 174 192
19. P.F. Chinnery, and M. Zeviani 135th ENMC Workshop: Polymerase gamma and disorders of mitochondrial DNA synthesis, 21-23 September 2007. Naarden, The Netherlands Neuromuscul Disord 18 2008 257 267
20. R. Horvath, G. Hudson, and G. Ferrari Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene Brain 129 2006 1674 1684
21. C. Tzoulis, B.A. Engelsen, and W. Telstad The spectrum of clinical disease caused by the A467T and W748S POLG mutations: A study of 26 cases Brain 129 2006 1685 1692
22. G. Ferrari, E. Lamanea, and A. Donati Infantile hepatocerebral syndromes associated with mutations in the mitochondrial DNA polymerase-γ A Brain 128 2005 723 731
23. M.A. Graziewicz, M.J. Longley, and W.C. Copeland DNA polymerase gamma in mitochondrial DNA replication and repair Chem Rev 106 2006 383 405
24. Polymerase Gamma Gene Mutation Database. Available at: http://tools.niehs.nih.gov/polg/.
25. M.C. De Vries, R.J. Rodenburg, and E. Morava Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations Eur J Pediatr 166 2007 229 234
26. E. Wiltshire, G. Davidzon, and S. DiMauro Juvenile Alpers disease Arch Neurol 65 2008 121 124
27. J. Uusimaa, R. Hinttala, and H. Rantala Homozygous W748S mutation in the POLG1 gene in patients with juvenile-onset Alpers syndrome Epilepsia 49 2008 1038 1045
28. B.N. Harding Progressive neurological degeneration of childhood with liver disease (Alpers' disease) presenting in young adults J Neurol Neurosurg Psychiatry 58 1995 320 325
29. A.H. Hakonen, P. Isohanni, A. Paetau, R. Herva, A. Suomalainen, and T. Lonnqvist Recessive Twinkle mutations in early onset encephalopathy with mtDNA depletion Brain 130 2007 3032 3040
30. A.R. Bicknese, W. May, W.R. Hickey, and W.E. Dodson Early childhood hepatocerebral degeneration misdiagnosed as valproate hepatotoxicity Ann Neurol 32 1992 767 775
31. R.P. Saneto, I.-C. Lee, and M.K. Koenig POLG DNA testing as an emerging standard of care before instituting valproic acid therapy for pediatric seizure disorders Seizure 19 2010 140 146
32. N.I. Wolf, S. Rahman, and B. Schmitt Status epilepticus in children with Alpers' disease caused by POLG1 mutations: EEG and MRI findings Epilepsia 50 2009 1596 1607
33. B.A. Engelsen, C. Tzoulis, and B. Karlsen POLG1 mutations cause syndromic epilepsy with occipital lobe predilection Brain 131 2008 818 828
34. M.H. Tulinius, and I. Hagne EEG findings in children and adolescents with mitochondrial encephalomyopathies: A study of 25 cases Brain and Develop 13 1991 167 173
35. A.H. Hakonen, S. Heiskanen, and V. Juvonen Mitochondrial DNA polymerase W748S mutation: A common cause of autosomal recessive ataxia with ancient European origin Am J Hum Genet 77 2005 430 441
36. S. Winterhun, G. Ferrara, and L. He Autosomal recessive mitochondrial ataxia syndrome due to mitochondrial polymerase gamma mutation Neurology 64 2005 1204 1208
37. M. Gauthier-Villars, P. Landrieu, and V. Cormier-Daire Respiratory chain deficiency in Alpers syndrome Neuropediatrics 32 2001 150 152
38. G. Davidzon, M. Mancuso, and S. Ferraris POLG mutations and Alpers syndrome Ann Neurol 57 2005 921 923
39. K.V. Nguyen, E. Ostergaard, and S.H. Ravin POLG mutations in Alpers syndrome Neurology 65 2005 1493 1495
40. N.Z. Lax, R.G. Whittaker, and P.D. Hepplewhite Sensory neuronopathy in patients harboring recessive polymerase γ mutations Brain 135 2012 62 71
41. G. Van Goethem, P. Luoma, and M. Rantamaki POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement Neurology 63 2004 1251 1257
42. A. Simonati, M. Filosto, and C. Savio Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease) Acta Neuropathol 106 2003 57 65
43. S.G. Boyd, A. Harden, J. Egger, and G. Pampiglione Progressive neuronal degeneration of childhood with liver disease ("Alpers disease"): Characteristic neurophysiological features Neuropediatrics 17 1986 75 80
44. T.P. Bohan, E. Helton, and I. McDonald Effect of L-carnitine treatment for valproate-induced hepatotoxicity Neurology 56 2001 1405 1409
45. R. McFarland, G. Hudson, and R.W. Taylor Reversible valproate hepatotoxicity due to mutations in mitochondrial DNA polymerase gamma (POLG1) Arch Dis Child 93 2008 151 153
46. V. Fellman, and H. Kotarsky Mitochondrial hepatopathies in the newborn period Semin Fetal Neonatal Med 16 2011 222 228
47. F. Mochel, A. Slama, and G. Touati Respiratory chain defects may present only with hypoglycemia J Clin Endocrinol Metab 90 2005 3780 3785
48. C. Giordano, H. Powell, and M. Leopizzi Fatal congenital myopathy and gastrointestinal pseudo-obstruction due to POLG1 mutations Neurology 72 2009 11103 11105
49. C. Giordano, M. Sebastiani, and R. De Giorgio Gastrointestinal dysmotility in mitochondrial neurogastrointestinal encephalomyopathy is caused by mitochondrial DNA depletion Am J Pathol 173 2008 1120 1128
50. H.X. Bai, M.H. Ma, A.I. Orabi, S.U. Latif, V. Bhandari, and S.Z. Husain Novel characterization of drug-associated pancreatitis in children J Pediatr Gastroenterol Nutr 53 2011 423 428
51. S.B. Wortmann, R.J.T. Rodenburg, and A. Jonckheere Biochemical and genetic analysis of 3-mtehylglutaconic aciduria type IV: A diagnostic strategy Brain 132 2009 136 146
52. J.-W. Taanman, S. Rahman, and A.T. Pagnamenta Analysis of mutant DNA polymerase γ in patients with mitochondrial DNA depletion Hum Mutat 30 2009 248 254
53. D. Dimmock, L.-Y. Tang, E.S. Schmitt, and L.J. Wong Quantitative evaluation of the mitochondrial DNA depletion syndrome Clin Chem 56 2010 1119 1127
54. G. Kollberg, A.-R. Moslemi, and N. Darin POLG1 mutations associated with progressive encephalopathy in childhood J Neuropathol Exp Neurol 65 2006 463 469
55. I. Taylor, I.E. Scheffer, and S.F. Berkovic Occipital epilepsies: Identification of specific and newly recognized syndromes Brain 126 2003 753 769
56. R.P. Saneto, S. Friedman, and D.W.W. Shaw Neuroimaging in mitochondrial disease Mitochondrion 8 2008 396 413
57. L.S. Kaguni DNA polymerase gamma, the mitochondrial replicase Annu Rev Biochem 73 2004 293 320
58. M.J. Longley, R. Prasad, D.K. Srivastava, S.H. Wilson, and W.C. Copeland Identification of 5′deoxyribose phosphate lyase activity to human DNA polymerase gamma and its role in mitochondrial base excision repair in vitro Proc Natl Acad Sci USA 95 1998 12244 12248
59. N. Lecrenier, P. Van Der Gruggen, and F. Poury Mitochondrial DNA polymerase from yeast to man: A new family of polymerases Gene 185 1997 147 152
60. Y.-S. Lee, W.D. Kennedy, and Y.W. Yin Structural insight into processive human mitochondrial DNA synthesis and disease-related polymerase mutations Cell 139 2009 312 324
61. Y.-S. Lee, I.J. Molineux, and Y.W. Yin A single mutation in human mitochondrial DNA polymerase Pol gammaA affects both polymerization and proofreading activities, but only as a holoenzyme J Biol Chem 285 2010 28105 28116
62. S.S.L. Chan, M.J. Longley, and W.C. Copeland The common A467T mutation in the human mitochondrial DNA polymerase (POLG) compromises catalytic efficiency and interaction with the accessory subunit J Biol Chem 36 2005 31341 31346
63. L. Euro, G.A. Farnum, E. Palin, A. Suomalainen, and L.S. Kaguni Clustering of Alpers disease mutations and catalytic defects in biochemical variants reveal new features of molecular mechanism of the human mitochondrial replicase, Pol γ Nucleic Acids Res 39 2011 9072 9084
64. S.S.L. Chan, M. Longley, and W.C. Copeland Modulation of the W748S mutation in DNA polymerase gamma by the E1143G polymorphism in mitochondrial disorders Hum Mol Genet 15 2006 3473 3483
65. J.D. Stumpf, C.M. Bailey, D. Spell, M. Stillwagon, K.S. Anderson, and W.C. Copeland Mip1 containing mutations associated with mitochondrial disease causes mutagenesis and depletion of mtDNA in Saccharomyces cerevisiae Hum Mol Genet 19 2010 2123 2133
66. K. Szczepanowska, and F. Foury A cluster of pathogenic mutations in the 3′-5′ exonuclease domain of DNA polymerase gamma defines a novel module coupling DNA synthesis and degradation Hum Mol Genet 19 2010 3516 3529
67. S.S. Chan, and W.C. Copeland DNA polymerase gamma and mitochondrial disease: Understanding the consequence of POLG mutations Biochim Biophys Acta 1787 2009 312 319
68. J.D. Stewart, R. Horvath, and E. Baruffini Polymerase γ gene POLG determines the risk of sodium valproate-induced liver toxicity Hepatology 52 2010 1791 1796
69. H. Yamanaka, H. Gatanaga, and P. Kosalaraksa Novel mutation of human DNA polymerase γ associated with mitochondrial toxicity induced by anti-HIV treatment J Infect Dis 195 2007 1419 1425
70. C.M. Bailey, R. Kasiviswanathan, W.C. Copeland, and K.S. Anderson R964C mutation of DNA polymerase γ imparts increased stavudine toxicity by decreasing nucleoside analog discrimination and impairing polymerase activity Antimicrob Agents Chemother 53 2009 2610 2612
71. J.A. Smeitink, M. Zeviani, D.M. Turnbull, and H.T. Jacobs Mitochondrial medicine: A metabolic perspective on the pathology of oxidative phosphorylation disorders Cell Metabol 3 2006 9 13
72. Naviaux RK. Alpers syndrome. Available at Orphan Net: http://www.orpha.net/consor/cgi-bin/OC-Exp.php?lng=EN&Expert=726.
73. A.H. Hakonen, G. Davidzon, and R. Salemi Abundance of the POLG disease mutations in Europe, Australia, New Zealand, and the United States explained by single ancient European origin Eur J Hum Genet 15 2007 779 783
74. K. Mohamed, W. FathAllah, and E. Ahmed Gender variability in presentation with Alpers' syndrome: A report of eight patients for the UAE J Inherit Metab Dis 34 2011 439 441
75. E. Gonzalez-Vioque, A. Bazquez, and D. Ferandez-Moreira Association of novel POLG mutations and multiple mitochondrial DNA deletions with variable clinical phenotypes in a Spanish population Arch Neurol 63 2006 107 111
76. O. Hasselmann, N. Blau, V.T. Ramaekers, E.V. Quadros, J.M. Sequeira, and M. Weissert Cerebral folate deficiency and CNS inflammatory markers in Alpers disease Mol Genet Metab 99 2010 58 61
77. G.M. Enns, S.L. Kinsman, and S.L. Perlman Initial experience in the treatment of inherited mitochondrial disease with EPI-743 Mol Genet Metab 105 2012 91 102
78. A. Safdar, J.M. Bourgeois, and D.I. Ogborn Endurance exercise rescues progeroid aging and induces systemic mitochondrial rejuvenation in mtDNA mutator mice Proc Natl Acad Sci USA 108 2011 4135 4140